| __timestamp | Alpine Immune Sciences, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 18516000 |
| Thursday, January 1, 2015 | 16054000 | 34140000 |
| Friday, January 1, 2016 | 23316000 | 51872000 |
| Sunday, January 1, 2017 | 10626000 | 71772000 |
| Monday, January 1, 2018 | 28970000 | 97501000 |
| Tuesday, January 1, 2019 | 35847000 | 118590000 |
| Wednesday, January 1, 2020 | 27185000 | 169802000 |
| Friday, January 1, 2021 | 58742000 | 192507000 |
| Saturday, January 1, 2022 | 70243000 | 199563000 |
| Sunday, January 1, 2023 | 80904000 | 253598000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Xencor, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Xencor, Inc. consistently outpaced Alpine Immune Sciences, Inc. in R&D spending, with an average annual expenditure nearly three times higher. Notably, in 2023, Xencor's R&D expenses reached a peak, marking a 37% increase from 2022. Meanwhile, Alpine Immune Sciences, Inc. showed a steady growth trajectory, with a 15% increase in the same period. This trend highlights Xencor's aggressive strategy in pioneering new treatments, while Alpine Immune Sciences, Inc. adopts a more measured approach. As the biotech landscape continues to shift, these spending patterns offer valuable insights into each company's strategic priorities and potential future breakthroughs.
AstraZeneca PLC or Xencor, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Xencor, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Xencor, Inc.
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
Ligand Pharmaceuticals Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Travere Therapeutics, Inc. vs Xencor, Inc.